Roche has decided to withdraw its immunotherapy Tecentriq as a treatment for a type of breast cancer in the United States. The drug received accelerated approval in 2019 to treat inoperable, locally advanced or metastatic triple-negative breast cancer (mTNBC) in people whose tumors express PD-L1, a protein that may help the cancer avoid detection by the immune system. But it failed last year…
Women’s Healthcare company TherapeuticsMD has announced that the Centers for Medicare and Medicaid Services (CMS) confirmed its preliminary recommendation to assign a permanent product-specific Healthcare Common Procedure Coding System (HCPCS) J Code for ANNOVERA. According to TherapeuticsMD, ANNOVERA (segesterone acetate and ethinyl estradiol vaginal system) is the first and only FDA-approved long-lasting, reversible contraceptive for women of reproductive age that is patient-controlled…
Studies have long drawn a connection between perinatal mood and anxiety disorders (PMADs), chronic stress and depression, as well as shortened gestational periods and even preterm birth. BehaVR is now using VR to create programs that change outcomes for both mom and baby for the better. Around 15-21% of moms-to-be suffer from perinatal mood and anxiety disorders, which often begin as early…
Bengaluru-based femtech startup Elda Health has raised a $1.5M seed round for it’s one-stop-shop holistic health platform targeting women aged 35 and up. The platform serves as an everyday companion for women on their healthcare journey, empowering them with measurable health outcomes. Avaana Capital, Orios Ventures and Ananth Narayanan Family Office participated in the round. “Women’s health has been underserved for generations.…
Women’s health today is under-served from innovation and clinical science standpoints with outdated practices and lack of much-needed attention from key players including investors and insurers. It is imperative to develop the eco-system, shift mindsets and embrace a holistic, women-centered approach. The Women’s Health Innovation Summit is the sector’s leading platform committed to strengthening the network, tackling unmet needs and championing innovative approaches and solutions. Our focus…
Hey Jane, a U.S. based virtual clinic startup offering reliable and accessible abortion care through telemedicine has raised $2.2M in an oversubscribed round from a group of investors including Koa Lab, Gaingels and Foursight Capital Partners. The idea for the remote-first company stemmed from a conversation in 2019 that founder and CEO Kiki Freedman had with some friends regarding Missouri being one…
Avestria Ventures invests in life science companies that have products or services which address unmet needs, improve healthcare quality and/or access, maintain or lower costs, and induce clinical or behavioral change. The company has now announced the closing of its new fund Avestria Ventures Fund I. Founded by veteran life science industry executives Linda Greub and Corinne Nevinny, Avestria invests in early-stage…
OrganiCare, the maker of all-natural over the counter healthcare products has announced the closing of an oversubscribed Series A financing of $8.5M after an aggressive 2020 year of growth, which included the launch of a new OTC Genital Herpes product under the FemiClear brand. “We are excited about the growth of OrganiCare,” said Jake Moilanen, General Partner at Seraph Group, and second time investor in…
